Finding the Formula for Scotland’s First Life Sciences Powerhouse Glenn Corr, TauRx COO
Scotland’s world-class life sciences sector now finds itself uniquely placed to achieve yet another major breakthrough. The country that gave the world cloning, penicillin, anaesthesia, insulin, beta blockers and the world’s first cancer-preventing vaccine, has the potential to build on its impressive reputation as a research hothouse by adopting a game-changing approach to commercialisation.
The life sciences sector is already one of Scotland’s greatest success stories with our small country ranking in the world’s top three for research impact. Our strong tradition of innovation encompasses everything from the MRI scanner to the hypodermic syringe, currently so crucial to the global vaccine roll-out.
Nearly 800 life science companies, employing 41,000 people, are based in the country. The industry has grown at a stunning 10% a year for the last decade and is well on track to meet and beat its ambitious target of £8bn turnover by 2025.
You can download the full article here.
The Scotsman Glenn Corr, TauRx COO Article
Scotland’s world-class life sciences sector now finds itself uniquely placed to achieve yet another major breakthrough.